首页> 外文OA文献 >CONSISTENCY OF IMPROVEMENT WITH GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN CHRONIC COUGH PATIENTS DURING WAKING HOURS AND OVER 24 HOURS

【2h】

CONSISTENCY OF IMPROVEMENT WITH GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN CHRONIC COUGH PATIENTS DURING WAKING HOURS AND OVER 24 HOURS

机译：GEFAPIXANT，P2X3受体拮抗剂，慢性咳嗽患者在醒出时期和超过24小时的一致性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anish Mehta; Alyn Morice; Surinder Birring; Lorcan McGarvey; Mandel Sher; David Muccino; Jacky Smith;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough [J] . Muccino David, Green Stuart Pulmonary pharmacology & therapeutics . 2019,第期

机译：关于GeFapixant的临床开发，P2X3受体拮抗剂治疗难治性慢性咳嗽的临床开发
2. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study [J] . Morice Alyn H., Kitt Michael M., Ford Anthony P., The European respiratory journal : . 2019,第1期

机译：GeFapixant，一种p2x3拮抗剂对咳嗽反射敏感性的影响：随机安慰剂对照研究
3. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study [J] . Alyn H. Morice, Michael M. Kitt, Anthony P. Ford, The European respiratory journal : . 2019,第1期

机译：GeFapixant，一种p2x3拮抗剂对咳嗽反射敏感性的影响：随机安慰剂对照研究
4. Nasopharyngeal acid reflux in patients with chronic otitis media evaluated by three-channel 24-hour pH monitoring [C] . Fukuda K., Yamazaki K., Ishijima K., Extraordinary International Symposium on Recent Advances in Otitis Media . 2009

机译：慢性中耳炎患者的鼻咽酸回流通过三通道24小时pH监测评估
5. Cardiac arrhythmias in patients with acute coronary syndrome within the first 24 hours of hospitalization. [D] . Winkler, Catherine Evelyn Gerowe. 2009

机译：住院前24小时内患有急性冠脉综合征的患者的心律不齐。
6. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant a P2X3 receptor antagonist in refractory or unexplained chronic cough [O] . David R. Muccino, Alyn H. Morice, Surinder S. Birring, 2020

机译：GeFapixantP2x3受体拮抗剂的两相3种随机对照试验（咳嗽-1和咳嗽-2）的设计和理论在难治性或无法解释的慢性咳嗽中
7. Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2) [O] . Alyn Morice, Surinder Birring, Peter Dicpinigaitis, 2021

机译：在P2X3受体拮抗剂GeFapixant（咳嗽-1和咳嗽-2）的两相3试验中，咳嗽患者患有难治性或无法解释的慢性咳嗽的患者中的患者触发和症状

CONSISTENCY OF IMPROVEMENT WITH GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN CHRONIC COUGH PATIENTS DURING WAKING HOURS AND OVER 24 HOURS

著录项

引文网络

相似文献

相关主题

期刊订阅